Vaccines are biological suspensions administered to prevent infectious diseases. Currently 100% imported, KSA has ambitions to localize manufacturing of various vaccine types (incl. toxoids, live attenuated, conjugates and recombinant protein vaccines).
القطاع
الأدوية والتكنولوجيا الحيوية
تحميل الفرصة
أبرز معالم الاستثمار
- Expected Investment size in USD: 50 – 500M per antigen (dependent on antigen chosen, design complexity, automation, utilities, contamination controls)
- Plant capacity: 80M – 120M doses annually
- Expected IRR: 15 – 20%
- Payback period: ~10 years
- Job Creation: ~500 jobs, mixture of advanced postgraduate manufacturing jobs, regulatory staff and blue-collar jobs e.g., packaging, logistics
- GDP Impact USD: 30M – 300M
- Location (Examples): KAEC, Jeddah, Qassim Industrial Area, NEOM OXAGON, Sudair, Riyadh, Tabuk